Skip to main content

Table 2 Demographic and clinical characteristics of subjects

From: Psychosis among "healthy" siblings of schizophrenia patients

  Patients Psychotic siblings Non psychotic siblings Comparison group
N 124 30 153 111
Age at evaluation, y, mean (SD), (min, max) 46.0 (7.3) (31.2 – 64.9) 44.4 (6.3) (32.0 – 61.0) 46.4 (8.8) (24.0 – 72.0) 50.3 (12.3) (30.3–78.0)
Sex of subjects, % male 81 65.3 % 16 53.3% 73 47.7% 56 50.5%
Education, y, mean (SD) 9.5 (2.3) 10.5 (2.1) 11.4 (3.0) 11.7 (4.0)
Ever had psychiatric treatment/medication 123 99.2 % 22 73.3 % 46 30.1 % 31 27.9%
Ever treated in psychiatric hospital 121 97.5% 9 30.0% 11 7.2% 4 3.6 %
Current psychiatric treatment/medication 117 94.4 % 13 43.3 % 19 12.4 % 16 14.4%
Current use of psychiatric medicine 117 94.4 % 13 43.3 % 19 12.4 % 12 10.8%
Antipsychotics 116 93.5 % 8 26.8 % 4 2.6 % 3 2.7%
Antidepressants 25 20.2 % 9 30.0 % 6 3.9 % 4 6.6%
Anxiolytics or sedatives 54 43.5 % 10 33.3 % 8 5.2 % 5 4.5%
GAF current (SD) 36.3 (11.3) 54.9 (11.8) 77.5 (12.5) 79.2 (12.9)